Pierre Fabre Pharmaceuticals Inc. is the US subsidiary of Pierre Fabre Laboratories, a foundation-owned multinational healthcare company with over 70 years of experience in the pharmaceutical and cosmetics industries. Headquartered in Parsippany, NJ, Pierre Fabre is dedicated to delivering innovative therapies in oncology and rare diseases, focusing on patient populations with significant unmet medical needs. The company operates globally, with a presence in 43 countries and products distributed in 119 territories. Pierre Fabre emphasizes the importance of pharmaceutical ethics, climate transition, and long-term partnerships with researchers and innovators. The organization is committed to improving patient experiences and outcomes through the development of advanced therapeutic solutions, including the upcoming launch of a groundbreaking allogeneic T-cell immunotherapy. With a strong focus on diversity and inclusion, Pierre Fabre fosters a collaborative work environment that values creativity and scientific curiosity.